Genotoxic stress-induced apoptosis is mediated by caspase family proteases as triggered by other stimuli. In this study, we found that the DNA-damaging agent cisplatin (cDDP) activated MAP kinase kinase kinase ASK1 and subsequent downstream subgroups of MAP kinase kinase, SEK1 (or MKK4) and MKK3/MKK6, which in turn activated c-Jun N-terminal kinase 1/stressactivated protein kinase (JNK1/SAPK) and p38 MAP kinase prior to caspase family protease activation and the onset of apoptosis in human ovarian carcinoma (OVCAR-3) and human kidney (293T) cells. As reported previously, benzyloxy carbonyl-Asp-CH 2 OC(O)-2, 6-dichlorobenzene (Z-Asp), a preferential inhibitor of caspase family proteases, blocked the apoptosis of OVCAR-3 cells induced by the genotoxic stress cDDP. Z-Asp, however, did not inhibit ASK1 activation and the subsequent kinase cascades. Overexpression of kinasenegative ASK1 (K709R), which inhibited ASK1 activation and the downstream MKK3-p38 and MKK4-JNK1 pathways, also suppressed the caspase protease activation and apoptosis induced by cDDP. These results indicate that the ASK1 pathway is involved in genotoxic stress-induced apoptosis and mediates apoptosis at a step upstream of caspase protease activation.
Introduction
Apoptosis, or programmed cell death, is a genetically controlled response for cells to commit suicide. The symptoms of apoptosis are viability loss accompanied by chromatin condensation, membrane blebbing, and packaging of nuclear fragments into small apoptotic bodies (Kerr et al., 1972; Wyllie et al., 1980) . Regulation of cell death is essential for normal development and elimination of cells that have suered serious damage, and it is an important defense against the emergence of cancer and other diseases. Perturbations of apoptosis contribute to the pathogenesis of several human diseases including cancer, acquired immunode®ciency syndrome, and neurodegenerative disorders (Thompson, 1995) . The realization that chemotherapy can also induce apoptosis in some cancer cells both in vitro and in vivo (Kaufmann, 1989; Meyn et al., 1994 Meyn et al., , 1995 Searle et al., 1975) indicates that apoptosis could play a very important role in cancer and cancer therapy. Thus, discovering ways to modulate apoptosis may have immense therapeutic potential.
Recent evidence indicates that mitogen-activated protein kinase (MAPK) family protein kinases, c-Jun N-terminal kinase 1/stress-activated protein kinase (JNK1/SAPK) and p38 MAP kinase (p38) are important mediators of apoptosis (Xia et al., 1995) . Several studies revealed that JNK1/SAPK activation and/or p38 MAP kinase activation are involved in apoptosis induced by dierent stimuli, such as gamma radiation-induced apoptosis in Jurkat T-cells (Chen et al., 1996a,b) , Glutamate-induced apoptosis in rat cerebellar granule cells (Kawasaki et al., 1997) , mIgMinduced apoptosis in human B lymphocytes (Graves et al., 1996) or apoptosis induced by genotoxic stresses, such as UV, X-ray, H 2 O 2 , heat (Butter®eld et al., 1997; Verheij et al., 1996; Zanke et al., 1996) and cell surface receptor Fas (Brenner et al., 1997; Goillot et al., 1997; Yang et al., 1997b) . Consistently, blockade of JNK activation promotes cell survival (Dickens et al., 1997; Park et al., 1996) . Although the emerging picture suggests that JNK/SAPK and/or p38 MAP kinase pathway function primarily to promote apoptotic cell death, a dierent picture showing controversial results is observed in many systems (Lenczowski et al., 1997; Liu et al., 1996b; Natoli et al., 1997; Nishina et al., 1997; Yang et al., 1997a) . Thus, much remains to be clari®ed about the biochemical regulation and cellular role of apoptotic kinase cascades. Recently, a new MAP kinase kinase kinase, termed apoptosis signal-regulating kinase1 (ASK1), was reported to activate two dierent subgroups of MAP kinase kinase, SEK1/MKK4 and MKK3/MKK6 which in turn activate JNK/SAPK and p38 MAP kinase, respectively. ASK1 is activated in cells treated with TNF-a and involved in TNF-a-induced apoptosis (Ichijo et al., 1997) .
Here we show that ASK1 is also involved in apoptosis triggered by chemotherapy. membrane blebbing, nuclear condensation, and the formation of apoptotic bodies. To determine whether the DNA damage induced apoptosis, we evaluated the occurrence of apoptotic nuclear changes using the DAPI staining technique. As shown in Figure 1a , the apoptotic cell percentage increased along with the drug treatment.
Numerous reports demonstrated that caspase family proteases, especially caspase-3, play a central role in executing apoptotic process (Nicholson et al., 1995; Tewari et al., 1995, Martin and Green, 1995; Nicholson and Thornberry, 1997) . To determine whether DNA damage induced a bona ®de apoptotic program in this system by activating the caspase family proteases, we observed processing of caspase-3. As shown in Figure  1b , caspase-3 was processed into p17 and p12 fragments after treating the cells with cDDP for more than 12 h, indicating the caspase-3 was activated during the genotoxic stress-induced cell death.
There is increasing evidence to indicate that a discrete subset of cellular proteins are cleaved by the caspases during apoptosis (Nicholson and Thornberry, 1997) . It was reported that PARP is one of the bestcharacterized putative death substrates, and it is cleaved into fragments during many forms of apoptosis (Kaufmann et al., 1993) . We therefore tested whether PARP was proteolytically cleaved in cells undergoing cDDP-induced cell death. Cell lysates from control, untreated cells and from cDDP-treated cells were probed for PARP cleavage by immunoblotting. PARP cleavage to a 85-kDa fragment was detected in the lysate from cells treated with cDDP. By contrast, cell lysates from untreated cells revealed only a major band of 116 kDa corresponding to the intact PARP protein (data not shown).
It is reported that cytochrome c plays a role in activation of caspase-3 (Liu et al., 1996a) . We found that cytochrome c was released to cytosol and paralleled the caspase activation by cDDP treatment (Figure 1b) .
Bax, Bcl-2 and Bcl-XL are involved in some apoptotic programs. However, we found no change during the apoptotic process of OVCAR-3 cells treated with cDDP ( Figure 1b ).
Genotoxic stress activates ASK1 and multiple downstream protein kinases in the early phase of apoptosis
During the development of apoptosis induced by the genotoxic stress cDDP, ASK1 activity in OVCAR-3 cells was detected by immunocomplex kinase assay with exogenous recombinant SAPK3 protein as a substrate (Ichijo et al., 1997) . As shown in Figure 2 , the ASK1 activity increased from 4 h after treatment with 15 mg/ ml of cDDP and maintained the activity at least through the 12 h time point. This ASK1 activation preceded the caspase-3 activation and the occurrence of apoptotic cell death (Figure 1 ). Since ASK1 lies upstream of the SEK1/MKK4-JNK/SAPK and MKK3/MKK6-p38 pathways (Ichijo et al., 1997) , we next examined the activation of the multiple downstream protein kinases by immunocomplex kinase assay (JNK/SAPK) or Western blot analysis using phosphospeci®c antibodies (SEK1/MKK4, MKK3 and p38). Figure 2 shows that treatment with cDDP that resulted in the activation of SEK1/MKK4, JNK/SAPK, MKK3/MKK6 and p38 kinases coincided with the ASK1 activation described above. When the cells were exposed to various dosages of cDDP, the activities of the kinases were enhanced in a dose-dependent manner (data not shown). Western blot analysis con®rmed equivalent levels of expression of the corresponding kinase proteins (data not shown), which suggests that the activations of the kinase cascades were not due to enhanced expression of related proteins.
These results indicate that the genotoxic stress cDDP lead to the activation of ASK1 and the following signaling kinase cascades.
Z-asp inhibits caspase-3 but not ASK1 activation DNA damaging agent-induced apoptosis requires caspase proteases, based on the ability of speci®c caspase inhibitors to inhibit genotoxic stress-induced (Mashima et al., 1995) . Since caspase-3 and the ASK1 pathway kinases are both activated by cDDP treatment, we investigated a possible regulatory relationship between them during cDDP-induced apoptosis in OVCAR-3 cells. Experiments were performed with the caspase inhibitor Z-Asp. OV-CAR-3 cells were treated with cDDP in the presence or absence of 100 mg/ml of Z-Asp, and each kinase activation was measured as described above. Consistent with earlier results (Figure 2 ), treatment of OVCAR-3 cells with cDDP for 6 h activated ASK1 and its downstream kinases. Intriguingly, Z-Asp did not inhibit the cDDP activation of ASK1 pathway kinases (Figure 3d ), although it completely prevented cDDPinduced apoptosis ( Figure 3a ) and cDDP-induced caspase-3 activation (Figure 3b and c). As a control, vehicle-treated cells or cells treated with Z-Asp alone neither caused apoptosis nor activated ASK1 pathway kinases and caspase-3. These results suggest that ASK1 and its downstream kinases could lie upstream of caspase proteases in a single cascade pathway. Alternatively, ASK1 and caspases might participate in independent parallel pathways.
Expression of catalytically inactive ASK1 mutant inhibits ASK1 activation and apoptosis
The cDDP activation of ASK1, which precedes caspase-3 activation, might be a prelude to the onset of apoptosis. To explore the direct role of ASK1 in cDDP-induced apoptosis, we examined the eect of a catalytically inactive mutant of ASK1 on cDDPinduced apoptosis in 293T cells. The ASK1 (K709R) is a nonphosphorylatable, competitive-inhibitory mutant of ASK1 in which Lys 709 was changed to Arg and contains a in¯uenza hemagglutinin epitope at the Nterminus. As shown in Figure 4b , treating 293T cells with 30 mg/ml of cDDP for 24 h or 48 h activated ASK1 kinase, while the ectopic expression of ASK1 (K709R) (Figure 4a ) reduced cDDP-stimulated ASK1 activation to the basal level, as de®ned by the immune complex kinase assay described above. We further determined the in¯uence of ASK1 (K709R) expression on the activation of downstream kinases, such as SEK1/MKK4, JNK/SAPK, MKK3/MKK6 and p38, after treatment with cDDP. As shown in Figure 4b , expression of the catalytically inactive ASK1 (K709R) strongly reduced all of the downstream kinase MKK3-p38 and MKK4-JNK pathways.
We further investigated the eect of expression of ASK1 (K709R) on the activation of caspase-3 and cleavage of the putative death substrate PARP. Figure  4c and d demonstrate that expression of ASK1 (K709R) attenuated caspase-3 activation and PARP cleavage triggered by cDDP treatment.
Having demonstrated that the expression of ASK1 (K709R) reduced cDDP-stimulated ASK1 and downstream kinase activation, we investigated the in¯uence of the ectopic expression of ASK1 (K709R) on apoptosis induced by cDDP. When 293T cells were treated with 30 mg/ml of cDDP for 48 h, apoptotic nuclear changes occurred as evaluated by the DAPI staining technique (not shown), and approximately 20% of cells underwent apoptosis as de®ned with¯ow cytometric analysis using PI (Figure 4e ). In contrast, cells expressing the ASK1 (K709R) construct were more resistant to cDDP-induced cell death than the mock-transfected cells. These ®ndings indicate that ASK1 was involved in genotoxic cDDP-induced apoptosis at a step upstream of caspase activation.
To further examine the eect of ASK1 (K709R) on the cDDP-induced apoptosis in OVCAR-3 cells, ASK1 (K709R) was transiently transfected into OVCAR-3 cells together with the gene encoding green¯uorescence protein (GFP). After treating the cells with cDDP for 18 h, the percentages of cells with apoptotic morphology in GFP-positive cells were counted under thē uorescence microscopy. Compare with 60% of apoptotic cells in mock cells, the apoptotic cells in ASK1 (K709R) cells was just about 30% (data not shown).
Discussion
The MAP kinase superfamily play an important role in cell growth, dierentiation, transformation and apoptosis (Cobb and Goldsmith, 1995; Dickens et al., 1997; Hunter, 1997; Karin, 1995; Xia et al., 1995) . But, the upstream kinase cascade events are poorly understood. Recently, a new MAP kinase kinase kinase, termed ASK1, was identi®ed that activates two dierent subgroups of MAP kinase kinase, SEK1/MKK4 and MKK3/MKK6, which in turn activate JNK/SAPK and p38 MAP kinase, respectively (Ichijo et al., 1997) . In the present study, we found that ASK1 was an important mediator in apoptosis triggered by genotoxic stress. When OVCAR-3 or 293T cells were Figure 2 Activation of ASK1 by the genotoxic agent stress cisplatin. OVCAR-3 cells were treated with 15 mg/ml of cDDP for the indicated periods of time. Cellular extracts were prepared, and kinase assay was determined by an in vitro-coupled assay with recombinant GST-MKK6 and GST-SAPK3 proteins as substrates after immunoprecipitating the endogenous ASK1 with ASK1 antiserum. MKK3, MKK4 and p38 activities were measured by immunoblot analysis, with the corresponding phospho-speci®c antibodies (New England Biolabs). JNK1 activity was monitored in an immune complex kinase assay by phosphorylation of bacterially expressed GST-c-Jun(1 ± 92) as a speci®c substrate treated with the genotoxic agent cDDP, the cells lost their adhesion to the culture dishes and died. Several tests for apoptosis were employed to determine that the cell death was, in fact, apoptosis. These include cell morphology, DAPI staining analysis of fragmented nuclei,¯ow cytometry, the activation of caspase proteases and the cleavage of death substrate PARP (Figures 1 and 4) . ASK1 was activated in the DNA damaging agent cDDP-treated cells prior to the onset of the apoptosis. Consistent with this kinase activation, its downstream kinases, including MKK3-p38 and SEK1/MKK4-JNK/SAPK, were activated by cDDP treatment with time kinetics paralleling the ASK1 activation (Figures 2 and 3) . These kinase activations were parallel with apoptosis, since cDDP led to the kinase activations in a dose-dependent fashion (data not shown). These observations suggest a correlation between ASK1-mediated activation of kinase cascades and apoptosis. Moreover, ASK1 (K709R), kinase negative mutant, signi®cantly inhibited both the cDDP activation of ASK1 and apoptosis (Figure 4 ). These results demonstrate that ASK1 is an important mediator of apoptosis induced by genotoxic stress.
Our previous work has shown that JNK/SAPK is involved in the apoptosis triggered by the genotoxic agent etoposide (VP-16) in U937 cells (Seimiya et al., 1997) . We also found that the genotoxic stress cDDP induced JNK/SAPK activation and apoptosis in cDDP-sensitive OVCAR-3 cells. However, JNK/ SAPK was not activated in relatively resistant OVCAR-8 cells, in which apoptosis was not induced by the same treatment (data not shown). These results factors because the JNK or p38 pathway culminates in the activation of transcription factors. c-Jun and GADD135 are reported to be involved in apoptosis through JNK and/or p38 pathways (Brenner et al., 1997; Verheij et al., 1996; Yang et al., 1997b) . In fact, increased c-Jun activity is sucient to trigger apoptotic cell death in NIH3T3 ®broblasts. The regions of c-Jun necessary for apoptosis induction include the aminoterminal transactivation and the carboxy-terminal leucine zipper domain, suggesting that c-Jun may activate cell death by acting as a transcriptional regulator (Bossy-Wetzel et al., 1997) . Very interestingly, in our stuty immuno¯uorescence analysis, cDDP induced translocation of JNK/SAPK and p38 from cytoplasma to nuclei together with the activations of these kinases (unpublished data). Since most of the possible JNK/p38 substrates are nuclear transcription factors, the nuclear translocation of the activated JNK/ SAPK and p38 could be related to their functions in the apoptosis through activation of a number of transcriptional factors.
There is ever-emerging evidence suggesting that caspase activation and the proteolytic cleavage of cellular substrates are common apoptotic phenomena. Our results showed that cDDP treatment led to activation of caspase-3 and PARP cleavage, which are preceded by the activation of ASK1. Our previous study demonstrated that JNK/SAPK lies upstream of the caspase proteases (Seimiya et al., 1997) . Consistently, Z-Asp, a caspase-speci®c protease inhibitor (Mashima et al., 1995) completely prevented the cDDP-induced cell death of OVCAR-3 cells but did not inhibit ASK1 activation at all. Furthermore, Z-Asp did not prevent activation of MKK3-p38 and MKK4-JNK kinases induced by cDDP treatment. In addition, ASK1 (K709R) overexpression attenuated both caspase-3 activation and PARP cleavage in accordance with apoptosis inhibition induced by the genotoxic agent cDDP. To our knowledge, this is the ®rst report of ASK1 mediating genotoxic stress-induced programmed cell death through regulation of MKK3/ MKK4-JNK/p38 pathways and caspase.
Recent reports suggest that the cdc42, Rac1, SEK1, JNK/p38 signaling pathways may play important roles in apoptosis (Brenner et al., 1997; Chuang et al., 1997; Mashima et al., 1995; Seimiya et al., 1997; Verheij et al., 1996; Zanke et al., 1996) . Our present ®ndings, consistent with our previous work (Ichijo et al., 1997; Seimiya et al., 1997) , reveal that ASK1 may be an important regulator in these pathways. Strictly speaking, the inhibitory eect of dominant-negative ASK1 (K709R) on cDDP-induced apoptosis was only partial (Figure 4 ). This result may re¯ect the functional redundancy of ASK1 and other MAPKKK family kinase isoforms in the superfamily MAP kinase cascades that make up the JNK and p38 pathways. On the other hand, although there is growing evidence suggesting a role for the JNK and p38 pathways in cell death, there may be other consequences of these kinase activations. For example, in some circumstances, JNK/ SAPK activation is part of a protective mechanism to regulate DNA repair and support cell survival (Potapova et al., 1997) . Furthermore, recent studies show that JNK, p38 and upstream kinase SEK1 are not only involved in apoptosis but are also important in the regulation of cell proliferation. For example, JNK is activated upon stimulation that induces cell proliferation or dierentiation (Berberich et al., 1996) , and SEK1/MKK4 protects thymocytes from apoptosis and is required for viability (Nishina et al., 1997; Yang et al., 1997a) . MKK4, however, is regarded as a candidate tumor suppressor (Teng et al., 1997) , suggesting that SEK1, JNK, p38 pathways may have bidirectional functions. A similar dual function for the regulation of cell proliferation/dierentiation or programmed cell death has been shown for c-Myc (Dong et al., 1997; Evan et al., 1992; Shi et al., 1992) , c-Fos (Colotta et al., 1992) , AP-1 (Angel and Karin, 1991; Sawai et al., 1995) , and cdc2 (Shi et al., 1994) . Therefore, the actual function of ASK1, SEK1/ MKK3, JNK/p38 pathways may depend on co-signals provided from dierent stimuli, cell type and environmental conditions. In summary, our study demonstrates an important function of ASK1-MKK3/MKK4-JNK/p38 pathways for genotoxic stress-induced programmed cell death. Further studies are needed to clarify the direct relationship between the ASK1-MKK4/MKK3-JNK/ p38 kinase cascades and the caspase protease activation.
Materials and methods

Materials
Cisplatin (cDDP) and etoposide (VP-16) were generous gifts from Bristol-Myers Squibb Co, Ltd. (Tokyo, Japan). Z-Asp was synthesized, as described previously (Mashima , 1995) . A¯uorogenic substrate for caspase-3 protease, DEVD-MCA, was purchased from the Peptide Institute (Osaka, Japan).
Cell lines and cell culture
Human ovarian carcinoma cell lines OVCAR-3 and human kidney 293T cells were maintained in DMEM medium (Nissui Co, Ltd. Tokyo, Japan) supplemented with 10% heat-inactivated fetal bovine serum and 100 mg/ml of kanamycin in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Drug treatment
Logarithmically growing OVCAR-3 or 293T cells were harvested by trypsinization and seeded in 10 ml of fresh medium in 10-cm dish. After overnight incubation, cDDP was added from 1000-fold concentrated stocks in dimethylsulfoxide (DMSO) with a ®nal concentration of 0.1% DMSO in medium, which had no in¯uence on cells. After various periods of incubation,¯oating cells and trypsinized adhesive cells were combined and sedimented at 800 g for 10 min and then a series of assays were performed.
Flow cytometry and nuclear staining assays
After treatment with cDDP, the cells were harvested by trypsinization and ®xed in 70% ethanol. Following treatment with RNase (1 mg/ml in 0.1 M phosphate buer, pH 7.0), the cells were stained in propidium iodide (PI) solution (50 mg/ml in 0.1% sodium citrate, 0.1% NP-40) and then analysed using a Becton Dickinson FACScan ow cytometer (Braintree, MA, USA).
Assay of caspase-3 and ICE proteolytic activity
The cDDP-treated cell lysate was incubated with 20 mM DEVD-MCA or YVAD-MCA at 378C for 120 min, and the release of amino-4-methylcoumarin (AMC) was monitored by a spectro¯uorometer (Hitachi F-2000) , using an excitation wavelength of 380 nm and an emission wavelength of 460 nm.
Western blot analysis
Western blot analysis was performed using the following antibodies: CPP32, Bcl-XL (Transduction Laboratories), cytochrome c, PARP (PharMingen), Bax (Upstate Biotechnology), and Bcl-2 (Boehringer Mannheim) according to instructions of the manufacturers. In brief, the cDDPtreated cell lysate was electrophoresed by SDS ± PAGE and then transferred to a nitrocellulose membrane. After blocking, the membrane was incubated with an anti-PARP antibody for 2 h at 258C. Immunodetection was performed using the enhanced chemiluminescence kit for Western blot detection (Amersham). Antiserum to the p12 fragment of caspase-3 was raised against a synthetic peptide sequence SGVDD conjugated to keyhole lympet hemocyanine.
Kinase assay
To prepare extracts, cells were lysed in a buer solution containing 20 mM tris-HCl (pH 7.5), 12 mM b-glycerophosphate, 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton X-100, 0.5% deoxycholate, 3 mM dithiothreitol (DTT), 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl gluoride (PMSF), and aprotinin (20 mg/ml). Cell extracts were clari®ed by centrifugation at 15 000 g for 10 min. For the ASK1 kinase assay, we used an in vitro-coupled kinase assay as described earlier (Ichijo et al., 1997) . Brie¯y, for immunoprecipitation, the supernatants were incubated with polyclonal antiserum to ASK1 (antiserum to ASK1 was raised against the peptide sequence TEEKGRSTEEGD-CESD amino acids 554 ± 669) or monoclonal antibody to HA(12CA5) for 1 h at 48C. After the addition of protein ASepharose (Pharmacia Biotech), the lysates were incubated for an additional 1 h. The beads were washed twice with a solution containing 500 mM NaCl, 20 mM tris-HCl (pH 7.5), 5 mM EGTA, 1% Triton X-100, 2 mM DTT and 1 mM PMSF, then twice with a solution containing 150 mM NaCl, 20 mM tris-HCl (pH 7.5), 5 mM EGTA, 2 mM DTT and 1 mM PMSF and subjected to kinase assays. To measure the activity of the immune complex, we ®rst incubated 0.2 mg of GST-MKK6 with the immune complex for 15 min at 308C in a ®nal volume of 25 ml of a solution containing 20 mM tris-HCl (pH 7.5), 10 mM MgCl 2 and 100 mM ATP and subsequently for 10 min at 258C with 0.3 mCi of [g-32 P]ATP and 3 mg of GST-SAPK3 (for GST-MKK6) in the same solution (®nal volume, 35 ml). The samples were then analysed by SDS ± PAGE and image analyzer (BAS1500, Fuji Film Co, Japan).
To measure the kinase activity of JNK1/SAPK, we used an immune complex kinase assay, as described previously (Seimiya et al., 1997) . Brie¯y, 1 mg of the cellular extract was incubated with protein A-Sepharose (Sigma) and 1 mg of rabbit anti-JNK1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 2 h at 48C. Immunoprecipitates were washed extensively and assayed for kinase activity at 378C for 20 min using 1.5 mg of GST/c-Jun-(1 ± 92) as a speci®c substrate. Proteins in the reaction were resolved by SDS ± PAGE and subjected to autoradiography. SEK1/MKK4, MKK3/MKK6 and p38 MAP kinase activities were assayed by Western blot analysis using phospho-speci®c SEK1/MKK4, MKK3/ MKK6 and p38 antibodies (New England Biolabs) according to the manufacturer's protocol.
DNA transfection
The pcDNA3-ASK1(K709R) plasmid was transfected into 293T cells by the calcium phosphate method or Superfect reagent (Qiagen) according to manufacturer's instructions together with pHook-1 plasmid (Invitrogen), which encodes a single-chain antibody fusion protein directed to the hapten phOx (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one) and thereby allows the selective isolation of transfected cells with magnetic beads coated with phOx. The ASK1 (K709R)-transfected cell populations were isolated on phOx-coated magnetic beads with the Capture-Teckit (Invitrogen), allowed to grow, counted and treated with cDDP, then a series of analyses were performed.
